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Background. Compared with antidepressant activity of Xiaoyaosan, the role of Xiaoyaosan in anxiety has been poorly studied.
Objective. To observe the effects of Xiaoyaosan on anxiety-like behavior induced by chronic immobilization stress (CIS) and further
explore whether these effects were related to CRF1R signaling. Methods. Adult male SD rats were randomly assigned to five groups
(𝑛 = 12): the nonstressed control group, vehicle-treated (saline, p.o.) group, Xiaoyaosan-treated (3.854 g/kg, p.o.) group, vehicletreated (surgery) group, and antalarmin-treated (surgery) group. Artificial cerebrospinal fluid (0.5 𝜇L/side) or CRF1R antagonist
antalarmin (125 ng/0.5 𝜇L, 0.5 𝜇L/side) was bilaterally administered into the basolateral amygdala in the surgery groups. Except for
the nonstressed control group, the other four groups were exposed to CIS (14 days, 3 h/day) 30 minutes after treatment. On days 15
and 16, all animals were subjected to the elevated plus-maze (EPM) and novelty suppressed feeding (NSF) test. We then examined
the expression of CRF1R, pCREB, and BDNF in the amygdala. Results. Chronic pretreatment with Xiaoyaosan or antalarmin
significantly reversed elevated anxiety-like behavior and the upregulated level of CRF1R and BDNF in the amygdala of stressed
rats. pCREB did not differ significantly among the groups. Conclusions. These results suggest that Xiaoyaosan exerts anxiolytic-like
effects in behavioral tests and the effects may be related to CRF1R signaling in the amygdala.

1. Introduction
The prescription of Xiaoyaosan was originally recorded in
Taiping Huimin Hejiju Fang, a book that was compiled in
the Song Dynasty (960–1127 A.D.) by the National Medical
Ministry. The book shows that Xiaoyaosan promotes the
flow of liver Qi and cures “Yu-syndrome” characteristic of
melancholy and depression [1, 2]. In China, the herbal remedy
has been widely prescribed for hysteria, mental stress, and
manic-depressive disorder [3]. Animal studies revealed that
Xiaoyaosan exerted antidepressive-like effects in tail suspension and forced swimming tests [4, 5]. Compared with the
antidepressant activity of Xiaoyaosan, the role of Xiaoyaosan
in anxiety has been poorly studied. Our preliminary study
found that chronic pretreatment with Xiaoyaosan produced
an anxiolytic-like effect on behavior in rats after exposure to

chronic immobilization stress (CIS) [6]. Based on our previous research, in the current study, we assessed the anxiolyticlike effects of chronically administered Xiaoyaosan on rats
after exposure to CIS.
As a major hormone and critical neurotransmitter
in the hypothalamic pituitary adrenocortical (HPA) axis,
corticotropin-releasing factor (CRF) is considered the main
neuropeptide in stress regulation [7, 8]. It has been hypothesized that CRF-1 receptor (CRF1R), which is widely expressed
in the pituitary and brain, may be intimately involved in
anxiety behavior [9]. Several signs of elevated anxiety were
found after CRF was centrally administered or in transgenic
mice overexpressing CRF [10]. Conversely, centrally administered antagonist of CRF receptor exerted anxiolytic effects
in rats [11, 12]. These data indicate that enhanced anxiety-like
behaviors occur upon activation of CRF1R.
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Although it has been demonstrated that the levels of
CRF1R mRNA transcripts were elevated in the hypothalamic
paraventricular nucleus (PVN) and amygdala after exposure
to immobilization stress in rats [13, 14], little is known about
the effect of Xiaoyaosan on the expression of CRF1R in rats
after exposure to immobilization stress. The critical function
of CRF1R in anxiety behavior and anxiolytic-like effect of
Xiaoyaosan raise the question whether CRF1R contributes to
the regulation of Xiaoyaosan on anxiety-like behavior in rats
after exposure to CIS. Thus, in the present study, we examined
CIS-induced anxiety-like behavior in rats using the elevated
plus-maze (EPM) and novelty suppressed feeding (NSF) test
and further examined CRF1R expression in the amygdala and
the role of the CRF1R signaling pathway in enhanced anxietylike behavior.

2. Materials and Methods
2.1. Animals. Healthy adult male Sprague-Dawley (SD) rats
(Harlan, Indianapolis, IN), initially weighing between 230 g
and 250 g, were used in the study. Rats were housed in
a temperature-controlled (24 ± 1∘ C) and light-controlled
(lights on 6:00 Am–6:00 Pm) environment. Two rats were
assigned to each cage and the rats had access to food and
water ad libitum. The animals were allowed 7 days to accommodate to the environment and were brought to the experiment room 30 min prior to each experiment. All behavioral
experiments were carried out between 9:00 Am and 5:00 Pm.
Housing and behavioral procedures were approved by the
Animal Care and Use Committee of West Virginia University
Health Sciences Center and conformed to the “NIH Guide for
the Care and Use of Laboratory Animals” [15].
2.2. Surgical Techniques. A drug infusion cannula was implanted above the basolateral amygdala (BLA) in 24 rats
by stereotaxic surgery. After intraperitoneal anesthesia with
ketamine (100 mg/kg) and xylazine (6 mg/kg), the rats were
placed in the stereotaxic apparatus (Stoelting, Wood Dale,
IL) on a heating pad. The incisor bar was set at −3.3 mm
to make the skull flat. Under aseptic conditions, a 23 gauge
guide cannula (Plastics One, Roanoke, VA) was inserted into
the BLA bilaterally (2.9 mm posterior to the bregma, 5.0 mm
lateral to the midline, and 8.5 mm ventral to the skull surface)
[16]. Two screws were then placed into the skull as anchors.
The guide cannula was secured using dental acrylic. After
surgery, ketoprofen (10 mg/kg, im) was administered. Three
days were allowed for rats to recover prior to subsequent
experimental procedures.
2.3. Drugs and Drug Administration. Xiaoyaosan contains
eight herbs including Poria cocos (Schw) Wolf (Poria) 300 g,
Paeonia lactiflora Pall (Radix paeoniae alba) 300 g, Glycyrrhiza uralensis Fisch (Radix glycyrrhizae) 150 g, Bupleurum chinense DC (Radix bupleuri) 300 g, Angelica sinensis
(Oliv.) Diels (Radix angelicae sinensis) 300 g, Atractylodes
macrocephala Koidz. (Rhizoma atractylodis macrocephalae)
300 g, Mentha haplocalyx Briq. (Herba menthae) 100 g, and
Zingiber officinale Rosc. (Rhizoma zingiberis ecens) 100 g.
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The herbs were authenticated by Dr. B. Liu, Department of
Botany, Beijing University of Chinese Medicine, according
to the size, shape, texture, color, and odor of the samples
specified in the Pharmacopoeia of the People’s Republic of
China 2010 Edition, Volume I before purchase from Tongrentang Drugstore in Beijing. Xiaoyaosan was extracted
and processed at Sino-Japan Friendship Hospital (Beijing).
The extraction procedures of Xiaoyaosan were described
previously [17–19]. For oral administration (via gavage, p.o.),
Xiaoyaosan was dissolved in saline and diluted to the desired
concentration. Xiaoyaosan (3.854 g/kg, p.o.) was administered daily for 14 days. The dose was found to be effective from
our previous studies [17–19].
CRF1R antagonist antalarmin (Tocris Bioscience,
Ellisville, MO) was dissolved in artificial cerebrospinal fluid
(aCSF) (containing 35% acetonitrile and 0.1% trifluoroacetic
acid) at the final concentration of 125 ng/0.5 𝜇L [20–22]
and injected into the BLA using 30-gauge microinjection
cannulas (Plastic One), which can fit into the guide cannulas
and extended 1 mm beyond. Antalarmin or aCSF (as vehicle)
was administered bilaterally at a rate of 0.5 𝜇L/min by using
a microinfusion pump. The cannula was left in place for
additional 60 seconds after microinfusion to allow diffusion.
The procedure was performed daily for 14 days.

2.4. Chronic Immobilization Stress (CIS). Sixty rats were randomly assigned to five groups (𝑛 = 12 per group) as follows:
the nonstressed control group, the vehicle-treated (saline,
p.o.) group, the Xiaoyaosan-treated (3.854 g/kg, p.o.) group,
the vehicle-treated (surgery) group, and the antalarmintreated (surgery) group. CIS was performed 30 min after drug
administration by using a soft rodent restrainer made of
plastics that closely fit to the rats’ body with two adjustable
soft belts, respectively, fixing the chest and abdomen. During
CIS, rats were kept in the prone position for 3 h every day,
between 9:00 AM and 5:00 PM, for 14 consecutive days. On
day 15-16, rats were subjected to the EPM and NSF test.
The rats were sacrificed between 2:00 PM and 5:00 PM after
behavioral experiments to minimize diurnal fluctuation [20].

2.5. Elevated Plus-Maze (EPM) Test. The EPM apparatus
consisted of several parts including one central part (8 ×
8 cm), two opposing open and closed arms (30 × 8 cm), and
nontransparent walls (30 cm in height). The experiment room
was light and temperature-controlled. Between every session,
both the platform and the wall were thoroughly cleaned using
10% ethanol spray. Rats were placed individually in the center
of the maze (50 cm above the floor) facing an open arm.
The EPM test was videotaped and recorded by using a video
camera. Indices including total distance moved, number of
entries into the open and closed arms, and total time spent in
the open and closed arms were calculated and analyzed using
the ethovision software (Noldus). Percentage of time spent on
and number of entries to open arms were examined as the
standard anxiety indices. Total distance moved was detected
as the indicator of locomotor activity.
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2.6. Novelty Suppressed Feeding (NSF) Test. The NSF test was
performed as described previously with minor modification
[23]. The NSF apparatus was a white, plastic, open chamber
(50 ∗ 50 ∗ 40 cm), with 2 cm wooden bedding placed on the
floor. Four pellets of food (regular chow) were placed in the
center. After food deprivation for 24 h, rats were individually
placed in the corner of the white chamber. The latency to
begin to chew the pellets was recorded for up to 5 min.
2.7. Western Blotting Assays. The protein levels of CRFR1,
pCREB, and BDNF in the amygdala were detected of four
rats from five groups each. After behavior experiments, the
brain tissue was dissected and stored at −80∘ C until analysis.
The procedures for processing the brain tissue and Western
blotting analysis were both conducted as described previously
[24, 25]. Denatured samples were electrophoresed by using
the sodium dodecyl sulfate-polyacrylamide (SDS-PAGE) gel,
and then transferred to a PVDF membrane by using an
electroblotting apparatus (Bio-Rad, Hercules, CA, USA).
After nonspecific blocking, the membrane was incubated
overnight at 4∘ C with a primary antibody (mouse anti-𝛽actin monoclonal antibody diluted to 1 : 1000, or goat antiCRF1R polyclonal antibody diluted to 1 : 500). After wash,
the membranes were incubated with secondary antibody
(goat anti-mouse antibody diluted to 1 : 10000) for 1 h. Protein
bands were examined at 800 nm wavelength by using a
fluorescence scanner of Odyssey Infrared Imaging System.
2.8. Statistical Analysis. Data were expressed as mean ± SEM
and analyzed using one-way analysis of variance (ANOVA)
followed by Bonferroni’s multiple comparison tests. The level
of significance for all statistical tests was set to 0.05.

3. Results
3.1. Effect of Xiaoyaosan on Rat Performance in the EPM
Test. The role of Xiaoyaosan in the regulation of anxietylike behaviors was assessed using the EPM test. For the
percentage of entries in open arms (Figure 1(b)), the stressed
groups treated with vehicle (saline, p.o. or aCSF, intraBLA infusion) showed enhanced anxiety-like behavior as
indicated by decrease in the percentage of entries in open
arms compared with the nonstressed control group (𝑝 <
0.01). Rats treated with Xiaoyaosan (3.854 g/kg, p.o.) or
antalarmin (125 ng/0.5 𝜇L, intra-BLA infusion) prior to CIS
exhibited a significant increase in the percentage of entries
in open arms compared to the nontreated or vehicle-treated
stressed group (𝑝 < 0.05). The stressed groups treated with
vehicle (saline, p.o. or aCSF, intra-BLA infusion) showed
a decrease in the percentage of time spent in open arms
(Figure 1(c)). Pretreatment with Xiaoyaosan or antalarmin
before CIS tended to prevent the decrease in the percentage of
time spent in open arms induced by CIS. However, there were
no significant differences among the groups in the percentage
of time spent in open arms. We also found no significant
difference in total distances travelled in 5 minutes among the
groups (Figure 1(a)).
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3.2. Effect of Xiaoyaosan on Rat Performance in the NSF Test.
To further examine the effect of Xiaoyaosan on anxietyrelated behavior, we performed NSF test. After 24-h food
deprivation, rats faced the conflicts between the drive to eat
and the fear of the brightly lit open space, in the center of
which the food pellet was placed. The latency to begin eating
was used as a crucial index of anxiety-like behavior because
classical anxiolytic drugs decrease it. The stressed groups
treated with vehicle (saline, p.o. or aCSF, intra-BLA infusion)
exhibited a significantly longer latency to begin eating than
the nonstressed control group (𝑝 < 0.01) (Figure 2(a)). Nevertheless, pretreatment with Xiaoyaosan (3.854 g/kg, p.o.)
or antalarmin (125 ng/0.5 𝜇L, intra-BLA infusion) prior to
CIS reversed enhanced anxiety-like behavior as indicated by
preventing the increase in latency compared to the vehicletreated stressed group (𝑝 < 0.05). No differences were
observed in feeding activity in the home cage or in weight
loss induced by food deprivation (Figures 2(b) and 2(c)).
3.3. Effect of Xiaoyaosan on the Expression of CRF1R, BDNF,
and pCREB in the Amygdala. In order to determine whether
the effects of Xiaoyaosan on CIS-induced anxiety-like behaviors were associated with CRF1R signaling in the amygdala,
which is considered to play a critical role in regulating such
behaviors, we determined the expression of CRF1R, BDNF,
and pCREB in different groups of rats. Compared to the
nonstressed control group, rats exposed to CIS exhibited
a significant increase in the expression of CRF1R in the
amygdala (𝑝 < 0.01) (Figure 3(a)), which, however, was
abated by pretreatment with Xiaoyaosan (3.854 g/kg, p.o.) or
antalarmin (125 ng/0.5 𝜇L, intra-BLA infusion) (𝑝 < 0.05).
The expression of BDNF was upregulated markedly in the
amygdala in the stressed groups treated with vehicle (𝑝 <
0.01) (Figure 3(b)), which was reversed by pretreatment
with Xiaoyaosan or antalarmin (𝑝 < 0.05). We found no
significant difference in pCREB protein levels among the
groups (Figure 3(c)).

4. Discussion
Our study showed that CIS elevated anxiety-like behavior of
rats as assessed in the EPM and NSF test. These rats showed
a marked decrease in the percentage of entries in open arms
and an increased latency to feed. Furthermore, chronic pretreatment with Xiaoyaosan or antalarmin significantly attenuated CIS-induced anxiety-like behavior. Western blotting
assays additionally showed increased expression of CRF1R
and BDNF in anxiety-related amygdala. Consistently, chronic
pretreatment with Xiaoyaosan reversed the upregulation of
CRF1R and BDNF in the amygdala of stressed rats. Based on
these data, the authors conclude that the effect of Xiaoyaosan
on stress-induced CRF1R hyperactivity in the amygdala may
be a crucial mechanism underlying its anxiolytic-like effect.
As a potent mediator of stress- and anxiety-related behaviors, CRF1Rs are abundantly expressed in the amygdala [26].
CRF1R is a GPCR that is coupled to the stimulatory G protein
Gas and can thus activate PKA and subsequently CREB [27].
However, some studies reported that both PKC [28] and PKA
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Figure 1: Elevated plus maze test. (a) The total distance moved. (b) The percentage of entries in open arms. (c) The percentage of time spent
in the open arms. Values are mean ± SEM with 10 rats in each group. ∗∗ 𝑝 < 0.01 versus the nonstressed control group. # 𝑝 < 0.05 versus the
vehicle-treated CIS group. $ 𝑝 < 0.05 versus the vehicle-treated CIS group after surgery.

signaling pathways are crucial for CRF1-mediated effects in
the amygdala, which may underlie anxiety-like behaviors. As
novel therapeutic agents, CRF1R antagonists (CRAs) have
been evaluated for depression, anxiety, and other stressrelated disorders [28]. Stress can induce HPA axis activation,
which could be reduced by CRAs via blocking pituitary and
possibly brain CRF1Rs [29]. In our study, anxiety-like behavior was found after exposure to CIS for 14 consecutive days.
This was also observed by Merali et al. [30] who demonstrated
that chronic stressor exposure (daily restraint for 14 days) was
associated with increased CRH and AVP expression, which
were associated with anxiety and depressive symptoms. In
our study, antalarmin (a CRA) reversed elevated anxiety-like

behavior induced by CIS as revealed by the EPM and NSF
test. This is in agreement with the study by Henry et al. [31]
who demonstrated that microinfusion of the CRF1 antagonist
antalarmin into the central amygdala reduced anxiogenic
effect induced by immobilization stress. Moreover, a recent
study showed that the administration of antalarmin into the
medial amygdala exerted an anxiolytic effect in elevated Tmaze test by decreasing avoidance latencies and modulating
the anxiogenic effects of CRF [32]. We further examined the
expression of CRF1R signaling molecules including CRF1R,
pCREB, and BDNF. We found that CRF1R and BDNF
were upregulated in the amygdala of rats after exposure to
CIS, which are consistent with a previous report showing

Evidence-Based Complementary and Alternative Medicine

5

300

2.0

∗∗

200

#

Food (g/100 g body weight)

Latency to feed (s)

∗∗

$

100

0

1.5

1.0

0.5

0.0
Surgery

Control

Surgery

Control

Stress
Control
Vehicle
Xiaoyaosan

Stress
Control
Vehicle
Xiaoyaosan

Vehicle
Antalarmin
(a)

Vehicle
Antalarmin
(b)

Lose of body weight (%)

100

80
60
40
20
0
Control

Surgery
Stress

Control
Vehicle
Xiaoyaosan

Vehicle
Antalarmin
(c)
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versus the vehicle-treated CIS group after surgery.

CIS-induced increase in BDNF expression in the BLA and
a decrease in BDNF levels in area CA3 in the hippocampus
[25]. Though expression of pCREB did not differ significantly
in the amygdala among the groups, this might be related
to the experimental design or time-dependent changes in
immobilization stress. The pattern of changes in pCREB in
the amygdala is complex and time dependent [33]. A previous
work found that predator stress-induced increases in pCREB
in the amygdala at 6 h followed by decreases at 24 h after stress
[34]. Delineation of complex changes of pCREB after stress
will require future examination at different time points.
On the other hand, as Xiaoyaosan contains multiple
ingredients, it is possible that a different mechanism may
be responsible for the anxiolytic effects of Xiaoyaosan.

As a traditional Chinese remedy, Xiaoyaosan has also been
studied for its chemical components. Our team has previously performed compositional analysis of Xiaoyaosan by
HPLC-LTQ-Orbitrap-MS [19] and identified 8 compounds,
including paeoniflorin, liquiritin, glycyrrhizic acid, ferulic
acid, saikosaponins A and C, curcumin, and Poria cocos
alcohol in Xiaoyaosan samples. The peaks of the compounds
aligned with those of Xiaoyaosan extracts by using the same
HPLC system, suggesting that these compounds may serve
as quality control references of Xiaoyaosan [19]. Due to its
multiple compounds, Xiaoyaosan targets both anxiety and
depression. A previous study showed that buspirone complex
with glycyrrhizic acid had a protective effect in preventing
anxiety behavior [35]. Curcumin is the active component of
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curcuma longa and ginger and has been reported to have
both antidepressant and anxiolytic effect [36–39]. A previous
study has shown noticeable anxiolytic effect of curcumin
against lead-induced anxiety in rats and central neuronal
monoaminergic neurotransmission, especially serotonin, was
highly involved [39]. Paeoniflorin, a monoterpene glycoside,
was observed to exert antidepressant-like effects via inhibition of oxidative stress and Ca (2+) overload and may be
of potential use in the treatment of neuropathic pain and
associated insomnia [40]. Liquiritin, a flavone compound
derived from Glycyrrhiza uralensis, has antidepressant-like
activity, which may be related to defense of liquiritin against
oxidative stress [41]. Recently, it has been reported that
stress enhances BLA neuronal excitation, and CRF and 𝛼1
NE receptors could modulate such activity [42]. Moreover,
many neurochemicals comprise the stress response system,
including norepinephrine, serotonin, and 𝛾-aminobutyric
acid [43]. In addition, the methanolic extract from Bupleurum falcatum, derived from Xiaoyaosan, has dose-dependent
antidepressant-like activity and the serotonergic and noradrenergic systems may act as the targets [44]. However,
as the components are very complicated, the analysis and
assessment of the disassembled prescription deserve further
research. In the present study, since CRF1R and BDNF
expression in the amygdala was modulated by pretreatment
with Xiaoyaosan, it is possible that the anxiolytic-like effects
of Xiaoyaosan are, at least in part, exerted through inhibition
of the CRF1R pathway. However, the detailed mechanisms
underlying the anxiolytic-like effects of Xiaoyaosan still
remain to be fully elucidated, and more investigations will be
required in future.

5. Conclusion
The results of this study show that Xiaoyaosan exerts
anxiolytic-like effects in behavioral tests, which, intriguingly,
may be related to CRF1R signaling in the amygdala. These
findings add to our understanding of the mechanisms of
the anxiolytic-like effects of Xiaoyaosan. Though our data
on changes in the expression of CRF1R and BDNF in the
amygdala upon treatment is preliminary, in view of previous
literature on the critical role of CRF1R signaling in anxiety, we
believe that the findings are valuable in guiding future studies.
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